Lipidomic analyses in epidemiology

International Journal of Epidemiology

Volumn 45, Issue 5, 2016, Pages 1329-1338

  Mundra, Piyushkumar A ^a   Shaw, Jonathan E ^a   Meikle, Peter J ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASSOCIATION; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; GENOMICS; HUMAN; INTEGRATION; LIPIDOMICS; LONGITUDINAL STUDY; MODEL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK; TECHNOLOGY; BLOOD; EPIDERMIS; LIPID METABOLISM; METABOLISM; STATISTICAL MODEL;

LIPID;

EPIDEMIOLOGIC STUDIES; EPIDERMIS; GENOMICS; HUMANS; LIPID METABOLISM; LIPIDS; MODELS, STATISTICAL;

EID: 85032027537     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyw112     Document Type: Review

References (56)

1. Min HK, Lim S, Chung BC, Moon MH. Shotgun lipidomics for candidate biomarkers of urinary phospholipids in prostate cancer. Anal Bioanal Chem 2011;399:823–30.
2. Rantamaki AH, Seppanen-Laakso T, Oresic M, Jauhiainen M, Holopainen JM. Human tear fluid lipidome: from composition to function. PloSOne 2011;6:e19553.
3. Huang Y, Zhu M, Li Z et al. Mass spectrometry-based metabolomic profiling identifies alterations in salivary redox status and fatty acid metabolism in response to inflammation and oxidative stress in periodontal disease. Free Radic Biol Med 2014;70:223–32.
4. Holcapek M, Cervena B, Cifkova E et al. Lipidomic analysis of plasma, erythrocytes and lipoprotein fractions of cardiovascular disease patients using UHPLC/MS, MALDI-MS and multivariate data analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2015;990:52–63.
5. Tyroler HA. Review of lipid-lowering clinical trials in relation to observational epidemiologic studies. Circulation 1987;76: 515–22.
6. Savolainen MJ. Epidemiology: disease associations and modulators of HDL-related biomarkers. Handb Exp Pharmacol 2015;224:259–83.
7. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837–47.
8. Quehenberger O, Dennis EA. The human plasma lipidome. N Engl J Med 2011;365:1812–23.
9. Weir JM, Wong G, Barlow CK et al. Plasma lipid profiling in a large population-based cohort. J Lipid Res 2013;54:2898–908.
10. Rached F, Lhomme M, Camont L et al. Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A. Biochim Biophys Acta 2015;1851:1254–61.
11. Kontush A, Lindahl M, Lhomme M, Calabresi L, Chapman MJ, Davidson WS. Structure of HDL: particle subclasses and molecular components. Handb Exp Pharmacol 2015;224:3–51.
12. Stahlman M, Fagerberg B, Adiels M et al. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles. Biochim Biophys Acta 2013;1831:1609–17.
13. Han X, Rozen S, Boyle SH et al. Metabolomics in early Alzheimer’s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PloS One 2011;6: e21643.
14. Haoula Z, Ravipati S, Stekel DJ et al. Lipidomic analysis of plasma samples from women with polycystic ovary syndrome. Metabolomics 2015;11:657–66.
15. Mapstone M, Cheema AK, Fiandaca MS et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 2014;20:415–18.
16. Meikle PJ, Mundra PA, Wong G et al. Circulating lipids are associated with alcoholic liver cirrhosis and represent potential biomarkers for risk assessment. PloS One 2015;10:e0130346.
17. de Mello VD, Lankinen M, Schwab U et al. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia 2009;52:2612–15.
18. Han X, Yang K, Gross RW. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom Rev 2012;31:134–78.
19. Stahlman M, Borén J, Ekroos K. High-throughput molecular lipidomics. Lipidomics Wiley-VCH Verlag GmbH & Co. KGaA 2012. p. 35–51.
20. Forouhi NG, Koulman A, Sharp SJ et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabet Endocrinol 2014;2:810–18.
21. De Livera AM, Dias DA, De Souza D et al. Normalizing and integrating metabolomics data. AnalChem 2012;84:10768–76.
22. Zivkovic AM, Wiest MM, Nguyen UT, Davis R, Watkins SM, German JB. Effects of sample handling and storage on quantitative lipid analysis in human serum. Metabolomics 2009;5: 507–16.
23. Meikle PJ, Wong G, Barlow CK, Kingwell BA. Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacol Ther 2014;143: 12–23.
24. Bellis C, Kulkarni H, Mamtani M et al. Human plasma lipidome is pleiotropically associated with cardiovascular risk factors and death. Circ Cardiovasc Genet 2014;7:854–63.
25. Niemela PS, Castillo S, Sysi-Aho M, Oresic M. Bioinformatics and computational methods for lipidomics. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:2855–62.
26. Hilario M, Kalousis A. Approaches to dimensionality reduction in proteomic biomarker studies. Brief Bioinform 2008;9: 102–18.
27. Wong G, Chan J, Kingwell BA, Leckie C, Meikle PJ. LICRE: unsupervised feature correlation reduction for lipidomics. Bioinformatics 2014;30:2832–33.
28. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach for multiple testing. J R Stat Soc B 1995;57:289–300.
29. Yu Z, Zhai G, Singmann P et al. Human serum metabolic profiles are age dependent. Aging Cell 2012;11:960–67.
30. Pietilainen KH, Sysi-Aho M, Rissanen A et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study. PloS One 2007;2:e218.
31. Haus JM, Kashyap SR, Kasumov T et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 2009;58:337–43.
32. Heimerl S, Fischer M, Baessler A et al. Alterations of plasma lysophosphatidylcholine species in obesity and weight loss. PloS One 2014;9:e111348.
33. Schwab U, Seppanen-Laakso T, Yetukuri L et al. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism - the GENOBIN study. PloS One 2008;3:e2630.
34. Kulkarni H, Meikle PJ, Mamtani M et al. Plasma lipidomic profile signature of hypertension in Mexican American families: specific role of diacylglycerols. Hypertension 2013;62:621–26.
35. Meikle PJ, Wong G, Barlow CK et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PloS One 2013;8:e74341.
36. Hodge AM, English DR, O’Dea K et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007;86:189–97.
37. Meikle PJ, Wong G, Tsorotes D et al. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 2011;31:2723–32.
38. Gonzalez-Covarrubias V, Beekman M, Uh HW et al. Lipidomics of familial longevity. Aging Cell 2013;12:426–34.
39. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62: 1198–211.
40. Demirkan A, Isaacs A, Ugocsai P et al. Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study. J Psychiatr Res 2013;47:357–62.
41. Blangero J, Diego VP, Dyer TD et al. A kernel of truth: statistical advances in polygenic variance component models for complex human pedigrees. Adv Genet 2013;81:1–31.
42. Fernandez C, Sandin M, Sampaio JL et al. Plasma lipid composition and risk of developing cardiovascular disease. PLoS One 2013;8:e71846.
43. Ganna A, Salihovic S, Sundstrom J et al. Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease. PLoS Genet 2014;10:e1004801.
44. Stegemann C, Pechlaner R, Willeit P et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation 2014;129: 1821–31.
45. Chaurasia B, Summers SA. Ceramides - lipotoxic inducers of metabolic disorders. Trend Endocrinol Metab 2015;26:538–50.
46. Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc 1996;58:267.
47. Ma S, Huang J. Penalized feature selection and classification in bioinformatics. Brief Bioinform 2008;9:392–403.
48. Saeys Y, Inza I, Larranaga P. A review of feature selection techniques in bioinformatics. Bioinformatics 2007;23:2507–17.
49. Baek S, Tsai CA, Chen JJ. Development of biomarker classifiers from high-dimensional data. Brief Bioinform 2009;10: 537–46.
50. Shin H, Markey MK. A machine learning perspective on the development of clinical decision support systems utilizing mass spectra of blood samples. J Biomed Inform 2006;39: 227–48.
51. Hyotylainen T, Oresic M. Optimizing the lipidomics workflow for clinical studies - practical considerations. Anal Bioanal Chem 2015;407:4973–93.
52. Oresic M. Informatics and computational strategies for the study of lipids. Biochim Biophys Acta 2011;1811:991–99.
53. Vihervaara T, Suoniemi M, Laaksonen R. Lipidomics in drug discovery. Drug Discov Today 2014;19:164–70.
54. Global Lipids Genetics C; Willer CJ, Schmidt EM, Sengupta S et al. Discovery and refinement of loci associated with lipid levels. Nat Genet 2013;45:1274–83.
55. Hicks AA, Pramstaller PP, Johansson A et al. Genetic determinants of circulating sphingolipid concentrations in European populations. PLoS Genet 2009;5:e1000672.
56. Laurila PP, Surakka I, Sarin AP et al. Genomic, transcriptomic, and lipidomic profiling highlights the role of inflammation in individuals with low high-density lipoprotein cholesterol. Arterioscler Thromb Vasc Biol 2013;33:847–57.